Organon & Co. (OGN) CMO exercises 11,519 RSUs and withholds 4,134 shares for costs
Rhea-AI Filing Summary
Organon & Co. executive Juan Camilo Arjona Ferreira, Head of R&D & CMO, reported an option-style event involving restricted stock units. On August 11, 2026 he exercised or converted 11,519 restricted stock units into the same number of common shares. In a related transaction, 4,134 common shares were delivered or withheld at $13.62 per share for payment of exercise price or tax liability. Footnotes state each restricted stock unit represents a contingent right to one common share and vesting occurs in three equal installments with the final vesting on August 11, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 7,385 shares
Net Buy
3 txns
Insider
Arjona Ferreira Juan Camilo
Role
Head of R&D & CMO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F2 | 11,519 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,519 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 4,134 | $13.62 | $56K |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 37,432.477 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock.
- F2. These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments with the third and final vesting occurring on August 11, 2026.
Key Figures
RSUs exercised or converted: 11,519 units
Common shares acquired: 11,519 shares
Shares delivered/withheld for costs: 4,134 shares
+2 more
5 metrics
RSUs exercised or converted
11,519 units
Restricted stock units converted into common stock on August 11, 2026
Common shares acquired
11,519 shares
Shares of Organon common stock received from RSU exercise or conversion
Shares delivered/withheld for costs
4,134 shares
Common shares delivered or withheld for payment of exercise price or tax liability
Per-share value for cost payment
$13.62 per share
Price applied to 4,134 shares for exercise price or tax liability
Final vesting date
August 11, 2026
Third and final vesting of the restricted stock units
Key Terms
Restricted Stock Units, contingent right, vest, tax liability
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"represents a contingent right to receive one share of Organon & Co. common stock"
vest financial
"These restricted stock units vest and are distributed as shares of Organon common stock"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
FAQ
What insider transaction did OGN executive Juan Camilo Arjona Ferreira report?
Juan Camilo Arjona Ferreira reported exercising or converting 11,519 restricted stock units into 11,519 shares of Organon common stock, plus a related disposition of 4,134 shares for payment of exercise price or tax liability.
What was the size of the RSU exercise reported for Organon (OGN)?
The filing shows an exercise or conversion of 11,519 restricted stock units, resulting in issuance of 11,519 shares of Organon common stock, with each restricted stock unit corresponding to one share of common stock.
Were the Organon (OGN) insider transactions under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmative, indicating these transactions were not reported as being made pursuant to a Rule 10b5-1 trading plan.
When do the reported Organon (OGN) restricted stock units fully vest?
Footnotes state the restricted stock units vest and are distributed in three equal installments, with the third and final vesting occurring on August 11, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
